Business Description
Medigen Vaccine Biologics Corp
ISIN : TW0006547003
Description
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.06 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 16.13 | |||||
| Beneish M-Score | -2.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 207 | |||||
| 3-Year EBITDA Growth Rate | -16.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.3 | |||||
| 3-Year FCF Growth Rate | 14.2 | |||||
| 3-Year Book Growth Rate | 5.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.96 | |||||
| 9-Day RSI | 57.54 | |||||
| 14-Day RSI | 52.43 | |||||
| 6-1 Month Momentum % | -26.13 | |||||
| 12-1 Month Momentum % | -43.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.69 | |||||
| Quick Ratio | 10.52 | |||||
| Cash Ratio | 8.83 | |||||
| Days Inventory | 905.49 | |||||
| Days Sales Outstanding | 79.06 | |||||
| Days Payable | 25.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 6.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.42 | |||||
| Operating Margin % | -99.75 | |||||
| Net Margin % | -98.82 | |||||
| FCF Margin % | -16.93 | |||||
| ROE % | -16.22 | |||||
| ROA % | -11.74 | |||||
| ROIC % | -21.38 | |||||
| ROC (Joel Greenblatt) % | -32.8 | |||||
| ROCE % | -14.62 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 29.53 | |||||
| PS Ratio | 19.49 | |||||
| PB Ratio | 3.24 | |||||
| Price-to-Tangible-Book | 3.23 | |||||
| EV-to-EBIT | -17.72 | |||||
| EV-to-EBITDA | -22.71 | |||||
| EV-to-Revenue | 16.79 | |||||
| EV-to-FCF | -96.35 | |||||
| Price-to-Net-Current-Asset-Value | 5.94 | |||||
| Price-to-Net-Cash | 9.45 | |||||
| Earnings Yield (Greenblatt) % | -5.64 | |||||
| FCF Yield % | -0.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medigen Vaccine Biologics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 648.17 | ||
| EPS (TTM) (NT$) | -1.947 | ||
| Beta | 1.27 | ||
| Volatility % | 27.3 | ||
| 14-Day RSI | 52.43 | ||
| 14-Day ATR (NT$) | 1.274281 | ||
| 20-Day SMA (NT$) | 36.535 | ||
| 12-1 Month Momentum % | -43.99 | ||
| 52-Week Range (NT$) | 33.7 - 70.7 | ||
| Shares Outstanding (Mil) | 328.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medigen Vaccine Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medigen Vaccine Biologics Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medigen Vaccine Biologics Corp Frequently Asked Questions
What is Medigen Vaccine Biologics Corp(ROCO:6547)'s stock price today?
The current price of ROCO:6547 is NT$37.60. The 52 week high of ROCO:6547 is NT$70.70 and 52 week low is NT$33.70.
When is next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547)?
The next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547) is .
Does Medigen Vaccine Biologics Corp(ROCO:6547) pay dividends? If so, how much?
Medigen Vaccine Biologics Corp(ROCO:6547) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers